Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > The dogs are out barking again !!

<< Previous

Bullboard Posts

Next >>

Comment by Davepark5on Dec 08, 2022 10:54am

117 Views

Post# 35159053

RE:RE:RE:RE:RE:The dogs are out barking again !!

Noteable - you are a dunce. Renee Quentin and myself all hold this issue. We just have the sense to see that most of what you post is hopeless pumping. I think renee finally got to her basis and dumped out....my basis is in the low 2s I almost touched it and dumped out a few weeks back. Stupidly i hung on , Meanwhile SAVA has started its run to 100 and i am stuck here in cement overshoes

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?